EFFECTTO Trademark

Trademark Overview

On Wednesday, June 9, 2021, a trademark application was filed for EFFECTTO with the United States Patent and Trademark Office. The USPTO has given the EFFECTTO trademark a serial number of 79324974. The federal status of this trademark filing is REGISTERED as of Tuesday, August 8, 2023. This trademark is owned by VASU HEALTHCARE PVT. LTD.. The EFFECTTO trademark is filed in the Pharmaceutical Products category with the following description:

Capsules for medicines sold empty; medicine capsules for the treatment of enlarged prostate and urinary tract related disorders; medicines for human purposes for the treatment of enlarged prostate and urinary tract related disorders; nutraceuticals for use as a dietary supplement for enlarged prostate and urinary tract related disorders; nutritional supplements; pharmaceutical preparations for the treatment of enlarged prostate and urinary tract related disorders; syrups for pharmaceutical purposes, namely, for the treatment of enlarged prostate and urinary tract related disorders; pharmaceutical preparation for treatment of enlarged prostate, pharmaceutical preparation for treatment of urinary tract related disorders
effectto

General Information

Serial Number79324974
Word MarkEFFECTTO
Filing DateWednesday, June 9, 2021
Status700 - REGISTERED
Status DateTuesday, August 8, 2023
Registration Number7128843
Registration DateTuesday, August 8, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements

Goods and ServicesCapsules for medicines sold empty; medicine capsules for the treatment of enlarged prostate and urinary tract related disorders; medicines for human purposes for the treatment of enlarged prostate and urinary tract related disorders; nutraceuticals for use as a dietary supplement for enlarged prostate and urinary tract related disorders; nutritional supplements; pharmaceutical preparations for the treatment of enlarged prostate and urinary tract related disorders; syrups for pharmaceutical purposes, namely, for the treatment of enlarged prostate and urinary tract related disorders; pharmaceutical preparation for treatment of enlarged prostate, pharmaceutical preparation for treatment of urinary tract related disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVASU HEALTHCARE PVT. LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIN
Party NameVASU HEALTHCARE PVT. LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIN
Party NameVASU HEALTHCARE PVT. LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIN

Trademark Events

Event DateEvent Description
Thursday, November 9, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, November 8, 2023FINAL DISPOSITION PROCESSED
Wednesday, November 8, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 8, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 8, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 23, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 3, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 24, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, April 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 4, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, October 7, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 7, 2022FINAL REFUSAL E-MAILED
Friday, October 7, 2022FINAL REFUSAL WRITTEN
Tuesday, September 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 27, 2022REFUSAL PROCESSED BY IB
Thursday, March 10, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 10, 2022REFUSAL PROCESSED BY MPU
Tuesday, March 8, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 7, 2022NON-FINAL ACTION WRITTEN
Monday, February 28, 2022ASSIGNED TO EXAMINER
Friday, November 12, 2021APPLICATION FILING RECEIPT MAILED
Monday, November 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 4, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

effectto prostate urinary tract related enlarged disorders treatment pharmaceutical purposes medicines